Filed: 8/8/2024ACC: 0001085146-24-003570
📋 What this filing means
FIRST TURN MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $614.72M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$614.72M
Total AUM (reported)
14.36M
Total Shares
Allocation by class
COM$445.77M72.5%
SPONSORED ADR$59.84M9.7%
COM NEW$59.67M9.7%
COM PAR $.01$21.67M3.5%
ADS$20.07M3.3%
CL A$7.70M1.3%
Portfolio Concentration
Top 3$90.25M14.7%
4–10$159.82M26.0%
11–25$249.53M40.6%
Rest$115.12M18.7%
Top 3 weight
14.7%
Top 10 weight
40.7%
Voting Authority Distribution
Total shares with voting rights: 14.36M
Sole
Full voting authority
14.36M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole36
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
ARGENX SE
SOLEShares79.98K
TypeSH
Market value$34.39M
5.59%
Sole
79.98K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares181.67K
TypeSH
Market value$28.70M
4.67%
Sole
181.67K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares337.25K
TypeSH
Market value$27.15M
4.42%
Sole
337.25K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares186.58K
TypeSH
Market value$25.45M
4.14%
Sole
186.58K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares703.40K
TypeSH
Market value$24.05M
3.91%
Sole
703.40K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares347.34K
TypeSH
Market value$23.79M
3.87%
Sole
347.34K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares50.69K
TypeSH
Market value$23.76M
3.87%
Sole
50.69K
Shared
0.00
None
0.00
INSMED INC
SOLEShares323.36K
TypeSH
Market value$21.67M
3.52%
Sole
323.36K
Shared
0.00
None
0.00
TRANSMEDICS GROUP INC
SOLEShares139.78K
TypeSH
Market value$21.05M
3.42%
Sole
139.78K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares109.22K
TypeSH
Market value$20.06M
3.26%
Sole
109.22K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares184.90K
TypeSH
Market value$19.93M
3.24%
Sole
184.90K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares260.28K
TypeSH
Market value$19.65M
3.20%
Sole
260.28K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares252.28K
TypeSH
Market value$19.14M
3.11%
Sole
252.28K
Shared
0.00
None
0.00
MERUS N V
SOLEShares321.91K
TypeSH
Market value$19.05M
3.10%
Sole
321.91K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares41.90K
TypeSH
Market value$18.64M
3.03%
Sole
41.90K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares695.43K
TypeSH
Market value$18.36M
2.99%
Sole
695.43K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares160.10K
TypeSH
Market value$18.15M
2.95%
Sole
160.10K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares369.98K
TypeSH
Market value$16.81M
2.73%
Sole
369.98K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares369.30K
TypeSH
Market value$16.54M
2.69%
Sole
369.30K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares293.32K
TypeSH
Market value$15.89M
2.59%
Sole
293.32K
Shared
0.00
None
0.00
ALPHATEC HLDGS INC
SOLEShares1.36M
TypeSH
Market value$14.22M
2.31%
Sole
1.36M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares397.78K
TypeSH
Market value$13.97M
2.27%
Sole
397.78K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares339.88K
TypeSH
Market value$13.25M
2.16%
Sole
339.88K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares640.39K
TypeSH
Market value$13.15M
2.14%
Sole
640.39K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares329.52K
TypeSH
Market value$12.79M
2.08%
Sole
329.52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARGENX SESOLE | SPONSORED ADR | 79.98K | SH | $34.39M 5.59% | 79.98K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 181.67K | SH | $28.70M 4.67% | 181.67K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 337.25K | SH | $27.15M 4.42% | 337.25K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 186.58K | SH | $25.45M 4.14% | 186.58K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 703.40K | SH | $24.05M 3.91% | 703.40K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 347.34K | SH | $23.79M 3.87% | 347.34K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 50.69K | SH | $23.76M 3.87% | 50.69K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 323.36K | SH | $21.67M 3.52% | 323.36K | 0.00 | 0.00 |
TRANSMEDICS GROUP INCSOLE | COM | 139.78K | SH | $21.05M 3.42% | 139.78K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 109.22K | SH | $20.06M 3.26% | 109.22K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 184.90K | SH | $19.93M 3.24% | 184.90K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 260.28K | SH | $19.65M 3.20% | 260.28K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 252.28K | SH | $19.14M 3.11% | 252.28K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 321.91K | SH | $19.05M 3.10% | 321.91K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 41.90K | SH | $18.64M 3.03% | 41.90K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 695.43K | SH | $18.36M 2.99% | 695.43K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 160.10K | SH | $18.15M 2.95% | 160.10K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 369.98K | SH | $16.81M 2.73% | 369.98K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 369.30K | SH | $16.54M 2.69% | 369.30K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 293.32K | SH | $15.89M 2.59% | 293.32K | 0.00 | 0.00 |
ALPHATEC HLDGS INCSOLE | COM NEW | 1.36M | SH | $14.22M 2.31% | 1.36M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 397.78K | SH | $13.97M 2.27% | 397.78K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 339.88K | SH | $13.25M 2.16% | 339.88K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 640.39K | SH | $13.15M 2.14% | 640.39K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 329.52K | SH | $12.79M 2.08% | 329.52K | 0.00 | 0.00 |
Page 1 of 2